For instance, combining EGFR inhibitors with inhibitors of key signaling molecules like MEK and C-RAF could not only more comprehensively suppress tumor proliferation signals but also decrease the adaptive resistance mechanisms of tumor cells to single agents (Blasco et al. 2019; Smalley and Smalley 2018). This evidence concerns the gene RAF1 and neoplasm.